About Eydiacure
Eydiacure is a Healthcare company. Manufacturing and supplying pharmaceutical products for healthcare services. Its Indian entity Eydia Cure Private Limited reported revenue of ₹11.02 Cr. Eydiacure offers products and services including Anti-Infective and Anti-Fungals and Supportive Therapy Products. Its focus areas include Pharmaceuticals, Drug Manufacturing, Anti-Infectives and Therapeutics.
Company details
Eydiacure is established by healthcare professionals with a focus on improving quality healthcare services globally. Products are manufactured at WHO-GMP and ISO-certified facilities, emphasizing innovation and adherence to strict quality standards. Ethical compliance is maintained through voluntary regulatory programs, ensuring that laws like the fair trade act are followed. Customer needs are prioritized in all operations, with a commitment to safety and environmental standards. The company is recognized for providing cost-effective solutions to unmet medical needs, fostering better health outcomes through dedication and innovation.
- SectorsHealthcare
- Email••••••••
- Legal Name Eydiacure Pvt Ltd
- Date of Incorporation 26 Aug, 2020
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹11.02 Cr
FY 2024 · +245% YoY
- Indian entity net profit₹29.2 Lakh
FY 2024 · 3% margin
- Indian entity EBITDA₹32 Lakh
FY 2024 · 3% margin
Associated legal entities of Eydiacure
Eydiacure operates through Eydia Cure Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Eydia Cure Private Limited CIN U24290DL2020PTC368740 | Active | 26 Aug 2020 | New Delhi, Delhi | ₹11.0 Cr | 19 | 4 | View details |
Products & Services of Eydiacure
Eydiacure offers a comprehensive portfolio of products and services, including Anti-Infective and Anti-Fungals and Supportive Therapy Products.
Anti-infective and anti-fungal drugs are manufactured for the treatment of infections and related conditions.
Supportive therapy products are developed to assist in patient care and improve health outcomes.
Board of directors of Eydia Cure Private Limited (Eydiacure)
Eydia Cure Private Limited is the primary company behind Eydiacure. The board of Eydia Cure Private Limited currently have 4 directors; the longest-serving is Ejazul Hasan, appointed in 2021. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ejazul Hasan DIN 07854420 | Director | 10 Aug 2021 | 5 yrs 2 mo | Eydia Cure Private Limited |
| Mohd Danish Israr DIN 09295660 | Director | 10 Aug 2021 | 5 yrs 2 mo | Eydia Cure Private Limited |
| Anant Kumar Pandey DIN 09295790 | Director | 10 Aug 2021 | 5 yrs 2 mo | Eydia Cure Private Limited |
| Nitin DIN 10149104 | Director | 06 May 2023 | 3 yrs 5 mo | Eydia Cure Private Limited |
Financials of Eydiacure
Figures of Eydia Cure Private Limited, the primary company behind Eydiacure, for FY 2024. Revenue was ₹11.02 Cr (+245% year on year). Net profit was ₹29.2 Lakh (3% margin). EBITDA was ₹32 Lakh (3% margin). Revenue has grown at a compounded annual rate of +492% over three years.
- ₹11.02 CrRevenue · FY 2024 · +245% YoY
- ₹29.2 LakhNet profit · 3% margin
- ₹32 LakhEBITDA · 3% margin
- ₹1 LakhPaid-up capital
- 19Employees (provident fund records)
- +492%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Eydia Cure Private Limited are on its company page.
Detailed financial statements for Eydiacure
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eydiacure
The primary company behind Eydiacure, Eydia Cure Private Limited, reported revenue of ₹11.02 Cr for FY 2024, up 245% year on year.
Eydiacure is established by healthcare professionals with a focus on improving quality healthcare services globally. Products are manufactured at WHO-GMP and ISO-certified facilities, emphasizing innovation and adherence to strict quality standards. Ethical compliance is maintained through voluntary regulatory programs, ensuring that laws like the fair trade act are followed. Customer needs are prioritized in all operations, with a commitment to safety and environmental standards. The company is recognized for providing cost-effective solutions to unmet medical needs, fostering better health outcomes through dedication and innovation.
Eydiacure offers Anti-Infective and Anti-Fungals and Supportive Therapy Products.
Eydiacure operates through Eydia Cure Private Limited.
The legal entities of Eydiacure currently have 4 directors, including Ejazul Hasan, Mohd Danish Israr, Anant Kumar Pandey and others.